RevCycle Intelligence August 16, 2018
The American Society of Clinical Oncology raised concerns that newly proposed Quality Payment Program changes would harm specialists caring for medically complex patients.
The American Society of Clinical Oncology (ASCO) recently expressed their concerns with proposed Quality Payment Program changes, arguing the potential implementation policies for the third year of the program do not align with specialty care.
“The recently released 2019 Quality Payment Program (QPP) rule in combination with the Medicare Physician Fee Schedule (MPFS) raises several questions about how oncology practices will be able to continue to provide the highest quality care for Medicare beneficiaries,” the group wrote to US House of Representatives Energy and Commerce Committee.
ASCO specifically took issue with the proposal to increase the weight...
Today's Sponsors
Today's Sponsor